Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
Open | $85.140 |
Close | $83.460 |
Volume / Avg. | 966.385K / 465.519K |
Day Range | 82.890 - 86.140 |
52 Wk Range | 70.740 - 95.260 |
Market Cap | $4.239B |
P/E Ratio | 34.504 |
Dividend Yield | - |
Exchange | NYSE |
RSI | 53 |
Short Interest | 6.1% |
Days to Cover | 4.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Other companies in Haemonetics’s space includes: Solventum (NYSE:SOLV), RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Embecta (NASDAQ:EMBC) and Align Tech (NASDAQ:ALGN).
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Friday, April 12, 2024. The analyst firm set a price target for 105.00 expecting HAE to rise to within 12 months (a possible 25.81% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Haemonetics (NYSE: HAE) is $83.46 last updated April 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Haemonetics.
Haemonetics’s Q4 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Haemonetics.
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.